#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	222	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1192	14.0	0	.	p	.	0	K29T	NONSYN	85	87	AAG	393	395	ACG	17;17;17	A;C;G	17;17;17	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1436	1438	AGC	21;21;21	A,G;G;C	10,11;21;21	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	L121Q	0	.	.	361	363	CTG	617	619	CTG	62;60;59	C;T;G	62;60;59	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	Q125E	0	.	.	373	375	CAG	629	631	CAG	55;57;59	C;A;G	55;57;58	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	Q125R	0	.	.	373	375	CAG	629	631	CAG	55;57;59	C;A;G	55;57;58	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	Q125K	0	.	.	373	375	CAG	629	631	CAG	55;57;59	C;A;G	55;57;58	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	Y161C	0	.	.	481	483	TAC	737	739	TAC	49;48;47	T;A;C	49;48;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	Y161D	0	.	.	481	483	TAC	737	739	TAC	49;48;47	T;A;C	49;48;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	Y161N	0	.	.	481	483	TAC	737	739	TAC	49;48;47	T;A;C	49;48;47	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1382	1384	GCA	43;42;43	G;C;A	43;42;43	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1382	1384	GCA	43;42;43	G;C;A	43;42;43	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1391	1393	GAA	38;36;36	G;A;A	38;36;36	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	0	HET	.	.	.	C99T	.	99	99	C	355	355	C	48	C,T	29,19	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	0	HET	.	.	.	T135C	.	135	135	T	391	391	T	48	T,C	22,24	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	0	HET	.	.	.	C216T	.	216	216	C	472	472	C	58	C,T	30,28	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	868	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1662	37.8	0	HET	.	.	.	C954T	.	954	954	C	1210	1210	C	58	C,T	31,27	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	416	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c4.ctg.1	1683	18.4	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1494	1496	AAA	18;18;18	A;A;A	18;18;18	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	470	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1782	19.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1300	1302	GAA	30;30;30	G;A;A	30;30;30	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	100	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	723	9.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	C990G	SNP	990	990	C	16	16	G	8	G	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	T1002A	SNP	1002	1002	T	28	28	A	9	A	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	A1003C	SNP	1003	1003	A	29	29	C	9	C	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	G1008C	SNP	1008	1008	G	34	34	C	9	C	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	C1011T	SNP	1011	1011	C	37	37	T	9	T	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	T1012C	SNP	1012	1012	T	38	38	C	9	C	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	C1023A	SNP	1023	1023	C	48	48	A	10	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	.1025G	INS	1025	1025	T	51	51	G	10	G	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	T1041G	SNP	1041	1041	T	67	67	G	11	G	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	140	90.07	Pasteurella_multocida_16S.l15.c30.ctg.2	140	8.1	0	.	n	.	0	A1042T	SNP	1042	1042	A	68	68	T	11	T	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	64	G	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	68	C	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	80	C	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	118	T	118	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	138	C	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	114	C	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	95	A	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	87	A	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	89	A	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	82	T	82	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	80	C	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	73	C	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	74	A	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	74	G	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	74	C	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	77	T	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	82	G	82	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	77	G	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	78	T	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	104	T	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	104	G	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	98	C	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	98	A	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	74	C	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	68	C	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	47	A	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	48	A	48	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	55	G	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	57	C	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	66	T	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	65	G	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	67	T	66	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	516	1304	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	808	60.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	145	C	145	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	354	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1597	16.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	276	278	CGT	20;20;20	C;G;T	20;20;20	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	354	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1597	16.7	0	.	p	.	0	V30I	NONSYN	88	90	GTC	360	362	ATC	16;16;17	A;T;C	16;16;17	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	354	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1597	16.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1119	1121	GGC	23;23;24	G;G;C	23;23;24	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	488	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2027	17.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	203	205	AGC	10;10;10	A;G;C	10;10;10	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	488	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2027	17.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	605	607	CTA	19;19;19	C;T;A	19;19;19	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	488	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2027	17.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1124	1126	CAA	26;26;27	C;A;A	26;26;27	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	488	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2027	17.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1223	1225	GGT	31;29;29	G;G;T	30;29;29	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	488	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2027	17.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1793	1795	GTT	18;18;18	G;T;T	18;18;18	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	172	PmrE	1167	400	99.25	PmrE.l15.c30.ctg.1	546	7.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	519	521	GAA	3;3;4	G;A;A	3;3;4	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	172	PmrE	1167	606	95.87	PmrE.l15.c30.ctg.2	675	10.6	0	.	p	.	0	S225T	NONSYN	673	675	TCC	113	115	ACT	5;6;6	A;C;T	5;6;6	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	512	172	PmrE	1167	606	95.87	PmrE.l15.c30.ctg.2	675	10.6	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	503	505	ATC	5;5;5	A;T;C	5;5;5	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	296	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1491	14.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	290	aad-	789	789	100.0	aad-.l15.c30.ctg.1	1344	16.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	982	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3559	20.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	485	487	ATC	24;24;24	A;T;C	24;24;24	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	982	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3559	20.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2198	2200	AAG	21;21;21	A;A;G	21;21;21	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	380	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1680	16.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	331	333	GTC	8;8;8	G;T;C	8;8;8	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	380	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1680	16.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1072	1074	TGC	28;28;28	T;G;C	28;28;28	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	918	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3153	21.6	0	.	p	.	0	S46trunc	TRUNC	136	136	T	370	370	T	14	T	14	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	918	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3153	21.6	0	.	p	.	0	G148D	NONSYN	442	444	GGC	676	678	GAC	28;27;28	G;A;C	28;27;28	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	918	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3153	21.6	0	.	p	.	0	F240L	NONSYN	718	720	TTT	952	954	TTA	16;16;17	T;T;A	16;16;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	918	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3153	21.6	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1135	1137	AAT	9;10;10	A;A;T	9;10;10	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	918	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3153	21.6	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1922	1922	T	36	T	36	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	180	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1020	13.3	1	SNP	p	R45C	0	.	.	133	135	CGC	326	328	CGC	17;16;16	C;G;C	17;16;16	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	172	acrS	663	663	98.64	acrS.l15.c4.ctg.1	848	14.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	214	216	TTC	16;16;15	T;T;C	16;16;15	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	172	acrS	663	663	98.64	acrS.l15.c4.ctg.1	848	14.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	478	480	GGG	25;25;25	G;G,A;G	25;24,1;25	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	208	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1231	12.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	643	645	CTT	19;19;20	C;T;T	19;19;20	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	864	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3021	21.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	1996	1998	GCA	25;25;25	G;C;A	25;25;25	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	864	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3021	21.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2257	2259	ACC	22;21;20	A;C;C	22;21;20	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	864	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3021	21.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2566	2568	GCC	30;31;32	G;C;C	30;31;32	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	542	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2552	15.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	289	291	GCT	14;14;15	G;C;T	14;14;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	542	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2552	15.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	409	411	GAG	8;8;9	G;A;G	8;8;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	542	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2552	15.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	445	447	TGC	13;13;13	T;G;C	13;13;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	542	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2552	15.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	628	630	GTT	14;14;15	G;T;T	14;14;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	542	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2552	15.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	778	780	CAC	19;20;20	C;A;C	19;20;20	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	542	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2552	15.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1063	1065	ATG	23;23;23	A;T;G	23;23;23	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	542	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2552	15.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2059	2061	CGC	23;22;22	C;G;C	23;22;22	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	268	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1083	18.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	803	805	ACC	11;11;10	A;C;C	11;11;10	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	268	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1083	18.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	815	817	TCG	11;11;11	T;C;G	11;11;11	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	218	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1221	13.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	360	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1665	15.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1317	1319	AAA	10;10;10	A;A;A	10;10;10	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	360	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1665	15.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1329	1331	GAG	12;12;13	G;A;G	12;12;13	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	360	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1665	15.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1335	1337	CAC	12;12;12	C;A;C	12;12;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	360	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1665	15.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1389	1391	GAG	16;15;15	G;A;G	16;15;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	446	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1932	17.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	256	cpxR	699	699	99.43	cpxR.l6.c4.ctg.1	1064	17.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	238	cysB	975	975	99.28	cysB.l15.c30.ctg.1	1271	13.9	0	.	p	.	0	A146T	NONSYN	436	438	GCT	651	653	ACT	17;18;18	A;C;T	17;18;18	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	110	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	767	10.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	348	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1447	17.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	895	897	GTC	26;26;25	G,A;T;C	25,1;26;25	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	564	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	1957	21.5	0	.	p	.	0	E197K	NONSYN	589	591	GAA	832	834	AAA	22;22;21	A;A;A	21;22;21	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	426	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1681	18.6	0	.	p	.	0	G209S	NONSYN	625	627	GGC	824	826	AGC	28;27;25	A;G;C	28;26;25	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	14	emrE_1	333	104	96.15	emrE_1.l15.c4.ctg.1	118	4.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	198	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1470	10.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	746	748	AGG	16;16;15	A;G;G	16;16;15	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	198	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1470	10.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1136	1138	GAC	8;8;9	G;A;C	8;8;9	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	186	emrR	531	531	100.0	emrR.l15.c4.ctg.1	935	14.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	310	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1944	11.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	120	evgA	615	615	99.19	evgA.l15.c4.ctg.1	892	9.8	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	299	301	CTG	12;12;12	C;T;G	12;12;12	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	394	396	ATA	18;18;17	A;T;A	18;18;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	406	408	GTA	19;20;20	G;T;A	18;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	559	561	ACG	9;9;9	A;C;G	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	622	624	GAA	10;10;10	G;A;A	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	661	663	GCT	8;7;7	G;C;T	8;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	679	681	GAT	8;9;9	G;A;T	8;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	766	768	TCA	10;11;11	T;C;A	10;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	895	897	CAG	7;7;7	C;A;G	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1033	1035	GTT	15;15;15	G;T;T	15;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1189	1191	GAT	8;9;10	G;A;T	8;9;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1357	1359	AAT	6;6;6	A;A;T	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1378	1380	TTA	2;3;3	T;T;A	2;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1579	1581	AAA	12;12;14	A;A;A	12;12;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2314	2316	CAT	12;12;13	C;A;T	12;12;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2368	2370	CAT	11;11;12	C;A;T	11;11;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2386	2388	AGA	15;14;14	A;G;A	15;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2401	2403	AAT	12;11;11	A;A;T	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2548	2550	TCC	12;13;12	T;C;C	12;13;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2713	2715	ATT	11;11;11	A;T;T	11;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2734	2736	GAT	16;16;16	G;A;T	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2848	2850	GTT	18;17;17	G;T;T	18;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	742	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4169	13.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3133	3135	CAC	14;14;13	C;A;C	14;14;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	292	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1329	16.4	1	SNP	p	P64A	0	.	.	190	192	CCA	395	397	CCA	24;26;26	C;C;A	24;26;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	292	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1329	16.4	1	SNP	p	P64R	0	.	.	190	192	CCA	395	397	CCA	24;26;26	C;C;A	24;26;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	292	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1329	16.4	1	SNP	p	P64S	0	.	.	190	192	CCA	395	397	CCA	24;26;26	C;C;A	24;26;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	292	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1329	16.4	1	SNP	p	P64H	0	.	.	190	192	CCA	395	397	CCA	24;26;26	C;C;A	24;26;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	292	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1329	16.4	1	SNP	p	P64L	0	.	.	190	192	CCA	395	397	CCA	24;26;26	C;C;A	24;26;25	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	144	gadE	528	528	100.0	gadE.l15.c4.ctg.1	868	11.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	24	gadW	729	200	96.0	gadW.l15.c4.ctg.1	287	4.5	0	.	p	.	0	S234A	NONSYN	700	702	TCG	171	173	GCG	6;6;6	G;C;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	24	gadW	729	150	96.0	gadW.l15.c4.ctg.2	153	2.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	158	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1311	9.0	0	.	p	.	0	F53L	NONSYN	157	159	TTC	452	454	TTA	8;8;9	T;T;A	7;7;8	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	158	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1311	9.0	0	.	p	.	0	V79I	NONSYN	235	237	GTT	530	532	ATT	8;8;8	A;T;T	8;8;8	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	158	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1311	9.0	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1031	1033	GGA	8;9;9	G;G;A	8;9;9	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	158	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1311	9.0	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1037	1039	CCG	9;9;9	C;C;G	9;9;9	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2284	2286	GAA	27;28;28	G;A;A	26;28;28	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	1	SNP	p	S83W	0	.	.	247	249	TCG	499	501	TCG	27;27;27	T;C;G	27;27;27	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	1	SNP	p	S83I	0	.	.	247	249	TCG	499	501	TCG	27;27;27	T;C;G	27;27;27	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	1	SNP	p	S83L	0	.	.	247	249	TCG	499	501	TCG	27;27;27	T;C;G	27;27;27	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	1	SNP	p	D87H	0	.	.	259	261	GAC	511	513	GAC	28;28;29	G,C;A;C	27,1;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	1	SNP	p	D87V	0	.	.	259	261	GAC	511	513	GAC	28;28;29	G,C;A;C	27,1;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	511	513	GAC	28;28;29	G,C;A;C	27,1;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	1	SNP	p	D87G	0	.	.	259	261	GAC	511	513	GAC	28;28;29	G,C;A;C	27,1;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3083	19.5	1	SNP	p	D87N	0	.	.	259	261	GAC	511	513	GAC	28;28;29	G,C;A;C	27,1;28;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	770	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2828	20.3	1	SNP	p	R136S	0	.	.	406	408	CGC	601	603	CGC	12;13;14	C;G;C	12;13;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	770	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2828	20.3	1	SNP	p	R136I	0	.	.	406	408	CGC	601	603	CGC	12;13;14	C;G;C	12;13;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	770	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2828	20.3	1	SNP	p	R136G	0	.	.	406	408	CGC	601	603	CGC	12;13;14	C;G;C	12;13;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	770	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2828	20.3	1	SNP	p	R136E	0	.	.	406	408	CGC	601	603	CGC	12;13;14	C;G;C	12;13;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	770	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2828	20.3	1	SNP	p	R136L	0	.	.	406	408	CGC	601	603	CGC	12;13;14	C;G;C	12;13;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	770	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2828	20.3	1	SNP	p	R136H	0	.	.	406	408	CGC	601	603	CGC	12;13;14	C;G;C	12;13;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	770	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2828	20.3	1	SNP	p	R136C	0	.	.	406	408	CGC	601	603	CGC	12;13;14	C;G;C	12;13;14	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	156	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1069	10.9	0	.	p	.	0	A72P	NONSYN	214	216	GCG	540	542	CCG	19;19;19	C;C;G	19;19;19	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	156	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1069	10.9	0	.	p	.	0	T123A	NONSYN	367	369	ACC	693	695	GCC	10;9;9	G;C;C	10;9;9	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	268	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1418	14.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	261	263	TCA	18;18;18	T;C;A	18;18;18	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	112	marA	384	384	99.74	marA.l15.c4.ctg.1	867	9.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	526	528	AGC	7;7;7	A;G;C	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	628	630	CAT	6;6;6	C;A;T	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	V45E	0	.	.	133	135	GTG	352	354	GTG	14;14;14	G;T;G	14;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	I49S	0	.	.	145	147	ATC	364	366	ATC	14;13;13	A;T;C	14;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	A70T	0	.	.	208	210	GCA	427	429	GCA	9;9;10	G;C;A	9;9;10	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	R73S	0	.	.	217	219	CGT	436	438	CGT	10;11;10	C;G;T	10;11;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	R73C	0	.	.	217	219	CGT	436	438	CGT	10;11;10	C;G;T	10;11;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	R77L	0	.	.	229	231	CGC	448	450	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	R77C	0	.	.	229	231	CGC	448	450	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	L78M	0	.	.	232	234	CTG	451	453	CTG	7;7;7	C;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	R94H	0	.	.	280	282	CGC	499	501	CGC	8;7;7	C;G;C	8;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	R94S	0	.	.	280	282	CGC	499	501	CGC	8;7;7	C;G;C	8;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	92	marR	435	435	97.7	marR.l15.c4.ctg.1	865	7.9	1	SNP	p	V96E	0	.	.	286	288	GTA	505	507	GTA	9;9;9	G;T;A	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	S7F	NONSYN	19	21	TCC	207	209	TTC	6;7;8	T;T;C	6;7;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	294	296	ATC	5;5;5	A;T;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	E42A	NONSYN	124	126	GAA	312	314	GCC	7;7;8	G;C;C	7;7;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	N43V	NONSYN	127	129	AAT	315	317	GTG	8;8;8	G;T;G	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	E52D	NONSYN	154	156	GAG	342	344	GAT	10;10;10	G;A;T	10;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	N59T	NONSYN	175	177	AAC	363	365	ACC	9;9;9	A;C;C	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	I68L	NONSYN	202	204	ATA	390	392	TTA	10;10;10	T;T;A	10;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	531	533	CAG	11;12;12	C;A;G	11;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	D128A	NONSYN	382	384	GAC	570	572	GCC	13;13;13	G;C;C	13;13;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	S163A	NONSYN	487	489	TCG	675	677	GCG	21;20;21	G;C;G	21;20;21	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	L231V	NONSYN	691	693	CTT	879	881	GTT	17;17;16	G;T;T	14;14;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	268	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1533	13.0	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1041	1041	C	16	C	16	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	224	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1602	10.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	229	229	G	9	G	9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	224	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1602	10.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	286	288	CAG	10;10;10	C;A;G	9;9;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	224	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1602	10.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	436	438	ATC	6;6;6	A;T;C	6;6;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	224	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1602	10.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	484	486	ATG	8;8;8	A;T;G	8;8;8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	224	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1602	10.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	577	579	ACC	9;9;8	A;C;C	9;9;8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	224	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1602	10.4	0	.	p	.	0	P257T	NONSYN	769	771	CCG	958	960	ACG	15;14;14	A;C;G	15;14;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1022	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3452	22.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1929	1931	ACC	25;26;26	A;C;C	25;26;26	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1022	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3452	22.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2322	2324	CAA	20;19;18	C;A;A	20;19;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1022	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3452	22.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2490	2492	ATT	18;18;18	A;T;T	18;18;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1022	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3452	22.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2574	2576	GTT	18;16;16	G;T;T	18;16;16	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1022	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3452	22.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2682	2684	GAG	21;21;21	G;A;G	21;21;21	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1022	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3452	22.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2910	2912	ATG	16;15;15	A;T;G	16;15;15	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1022	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3452	22.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3045	3047	GAT	23;24;24	G;A;T	23;24;23	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	946	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3513	20.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	324	326	ATG	13;13;13	A;T;G	12;13;12	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	946	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3513	20.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	810	812	ATC	33;33;33	A;T;C	33;33;33	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	946	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3513	20.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3126	3128	CAC	12;11;11	C;A;C	12;10;11	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	946	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3513	20.2	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3129	3131	CTC	11;11;11	C;T;C	11;11;10	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	452	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1979	17.1	0	.	p	.	0	D3E	NONSYN	7	9	GAT	283	285	GAA	7;7;7	G;A;A	7;6;7	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	452	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1979	17.1	0	.	p	.	0	T226A	NONSYN	676	678	ACG	952	954	GCG	22;22;24	G;C;G	22;22;24	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	452	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1979	17.1	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1294	1296	ATC	20;21;22	A;T;C	20;21;22	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	452	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1979	17.1	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1597	1599	TTT	20;20;20	T;T;T	20;20;20	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	422	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1701	18.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1000	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3614	20.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1158	1160	ACC	20;20;20	A;C;C	20;20;20	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1000	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3614	20.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2400	2402	GAC	15;15;16	G;A;C	15;15;16	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	348	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1610	14.1	0	.	p	.	0	V200I	NONSYN	598	600	GTC	625	627	ATC	18;18;18	A;T;C	18;18;18	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	348	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	551	5.5	0	.	p	.	0	E5G	NONSYN	13	15	GAA	170	172	GGA	8;9;8	G;G;A	8;9;8	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	334	mdtH	1209	1209	98.18	mdtH.l15.c17.ctg.1	1515	16.5	0	.	p	.	0	G134C	NONSYN	400	402	GGT	514	516	TGT	20;19;19	T;G;T	20;19;19	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	334	mdtH	1209	1209	98.18	mdtH.l15.c17.ctg.1	1515	16.5	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1084	1086	TTG	14;13;13	T;T;G	14;13;13	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	334	mdtH	1209	1209	98.18	mdtH.l15.c17.ctg.1	1515	16.5	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1294	1296	ACG	4;4;4	A;C;G	4;4;4	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	428	mdtL	1176	1176	98.38	mdtL.l6.c30.ctg.1	1688	19.0	0	.	p	.	0	A185S	NONSYN	553	555	GCC	839	841	TCC	19;19;19	T,G;C;C	18,1;19;19	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	282	mdtN	1032	1032	98.06	mdtN.l6.c30.ctg.1	1375	15.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	527	529	ATT	14;14;15	A;T;T	14;14;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	V11M	NONSYN	31	33	GTG	168	170	ATG	11;11;11	A;T;G	11;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	T33I	NONSYN	97	99	ACC	234	236	ATC	9;10;11	A;T;C	9;10;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	C116R	NONSYN	346	348	TGC	483	485	CGC	22;22;22	C;G;C	22;22;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	N238S	NONSYN	712	714	AAC	849	851	AGC	20;21;22	A;G;C	20;21;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1050	1052	GTG	19;20;20	G;T;G	19;19;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1113	1115	AAC	8;8;13	A;A;C	6;6;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1158	1160	GTC	17;18;18	G;T;C	17;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1188	1190	ATA	16;16;14	A;T;A	15;15;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1296	1298	TCT	16;16;16	T;C;T	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1683	1685	GCG	24;24;25	G;C;G	22;23;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	598	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2472	17.8	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1896	1898	ATC	23;24;24	A;T;C	23;23;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	591	593	GCG	17;17;16	G;C;G	17;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	765	767	ACC	17;17;16	A;C;C	17;17;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	837	839	CGC	20;20;21	C;G;C	20;20;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	954	956	GCT	15;15;15	G;C;T	15;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1038	1040	AAA	16;16;16	A;A;A	16;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1056	1058	CGA	16;16;16	C;G;A	16;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1221	1223	GCC	8;8;8	G;C;C	8;8;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1233	1235	GAT	9;9;9	G;A;T	9;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	334	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1817	13.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1650	1652	GCT	8;8;6	G;C;T	7;7;6	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1048	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3906	20.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1518	1520	AAG	22;23;23	A;A;G	22;23;23	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1048	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3906	20.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2595	2597	CTG	20;21;21	C;T;G	20;21;21	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	84	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	712	8.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	586	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2226	19.8	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1007	1009	AAC	21;21;20	A;A;C	21;21;20	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	586	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2226	19.8	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1553	1555	ATA	29;29;30	A;T;A	29;29;30	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	472	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1693	20.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1337	1339	GAT	22;22;22	G;A;T	22;22;22	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	472	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1693	20.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1340	1342	CTG	22;23;23	C;T;G	22;23;23	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	196	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1126	12.9	0	.	p	.	0	R27C	NONSYN	79	81	CGT	299	301	TGT	19;19;19	T;G;T	19;19;19	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	196	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1126	12.9	0	.	p	.	0	I117T	NONSYN	349	351	ATC	569	571	ACC	19;18;17	A;C;C	19;18;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	196	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1126	12.9	0	.	p	.	0	G187D	NONSYN	559	561	GGC	779	781	GAC	17;17;17	G;A;C	17;17;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	196	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1126	12.9	1	SNP	p	R15C	0	.	.	43	45	CGC	263	265	CGC	20;20;20	C;G;C	20;20;20	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	196	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1126	12.9	1	SNP	p	S33R	0	.	.	97	99	AGC	317	319	AGC	21;21;21	A;G;C	21;20;21	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	196	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1126	12.9	1	SNP	p	G131D	0	.	.	391	393	GGC	611	613	GGC	17;15;16	G;G;C	17;15;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	196	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1126	12.9	1	SNP	p	R203C	0	.	.	607	609	CGT	827	829	CGT	18;18;18	C;G;T	18;18;18	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	196	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1126	12.9	1	SNP	p	R203L	0	.	.	607	609	CGT	827	829	CGT	18;18;18	C;G;T	18;18;18	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	358	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1505	17.8	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1145	1147	GAG	24;24;24	G;A;G	24;24;24	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	358	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1505	17.8	1	SNP	p	G141D	0	.	.	421	423	GGT	632	634	GGT	30;29;28	G;G;T	30;29;27	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	358	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1505	17.8	1	SNP	p	G141E	0	.	.	421	423	GGT	632	634	GGT	30;29;28	G;G;T	30;29;27	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	358	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1505	17.8	1	SNP	p	R154D	0	.	.	460	462	CGT	671	673	CGT	23;23;23	C;G;T	23;23;23	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	358	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1505	17.8	1	SNP	p	R154A	0	.	.	460	462	CGT	671	673	CGT	23;23;23	C;G;T	23;23;23	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	828	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2596	23.8	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1807	1809	GTG	28;28;28	G;T;G	28;28;28	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	828	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2596	23.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1834	1836	TCG	32;32;33	T;C;G	31;31;33	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	828	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2596	23.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2449	2451	AAC	20;20;20	A;A;C	20;20;20	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	828	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2596	23.8	1	SNP	p	A85T	0	.	.	253	255	GCG	463	465	GCG	30;30;30	G;C;G	29;30;30	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	828	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2596	23.8	1	SNP	p	D111H	0	.	.	331	333	GAT	541	543	GAT	28;28;28	G;A;T	28;28;28	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	828	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2596	23.8	1	SNP	p	S129P	0	.	.	385	387	TCC	595	597	TCC	28;28;28	T;C;C	28;28;28	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	578	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2402	18.0	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1632	1634	AAC	28;27;28	A;A;C	28;27;28	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	578	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2402	18.0	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1641	1643	GAT	28;27;27	G;A;T	28;27;27	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	474	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1876	18.9	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	838	840	CAG	19;20;20	C;A,C;G	19;19,1;20	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	474	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1876	18.9	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1312	1314	GAT	22;22;21	G;A;T	22;22;21	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	V146F	0	.	.	436	438	GTT	661	663	GTT	26;25;25	G;T;T	26;25;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1762	1764	CAG	17;17;17	C;A;G	17;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1762	1764	CAG	17;17;17	C;A;G	17;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1801	1803	CAC	13;13;12	C;A;C	13;13;12	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1810	1812	CGT	16;16;17	C;G;T	16;16;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1810	1812	CGT	16;16;17	C;G;T	16;16;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1816	1818	TCC	17;17;18	T;C;C	17;17;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1822	1824	CTC	18;17;18	C;T;C	18;17;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1912	1914	ACC	22;23;23	A;C;C	22;23;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1915	1917	CCT	24;25;25	C;C;T	24;25;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1292	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4462	21.8	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2284	2286	CGT	31;31;31	C;G;T	31;31;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	.	n	.	0	A226G	SNP	226	226	A	253	253	G	208	G	208	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	1	SNP	n	A794G	0	.	.	794	794	A	821	821	A	203	A	202	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	1	SNP	n	A794T	0	.	.	794	794	A	821	821	A	203	A	202	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	1	SNP	n	G926T	0	.	.	926	926	G	953	953	G	188	G	187	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	1	SNP	n	G926A	0	.	.	926	926	G	953	953	G	188	G	187	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	1	SNP	n	G926C	0	.	.	926	926	G	953	953	G	188	G	187	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	1	SNP	n	A1519C	0	.	.	1519	1519	A	1546	1546	A	145	A	145	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	1	SNP	n	A1519G	0	.	.	1519	1519	A	1546	1546	A	145	A	145	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	1	SNP	n	A1519T	0	.	.	1519	1519	A	1546	1546	A	145	A	145	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	G1002A	.	1002	1002	G	1029	1029	G	186	G,A	117,67	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	G1006C	.	1006	1006	G	1033	1033	G	181	G,C	111,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	A79G,C	.	79	79	A	106	106	A	213	A,G,C	155,56,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	C719T	.	719	719	C	746	746	C	207	C,T	122,84	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	T273A	.	273	273	T	300	300	T	193	T,A	136,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	T1010C	.	1010	1010	T	1037	1037	T	179	T,C	109,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	C1038T	.	1038	1038	C	1065	1065	C	212	C,T	116,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	C183T	.	183	183	C	210	210	C	182	C,T	119,63	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	A250T,G	.	250	250	A	277	277	A	194	A,T,G	143,48,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	T90C	.	90	90	T	117	117	T	208	T,C	158,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	G474A,T	.	474	474	G	501	501	G	172	G,A,T	128,41,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	A253T,G	.	253	253	A	280	280	A	192	A,T,G	140,48,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	G895A	.	895	895	G	922	922	G	165	G,A	142,20	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	4302	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1796	170.8	0	HET	.	.	.	C194T	.	194	194	C	221	221	C	188	C,T	148,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	204	sat_1	525	525	100.0	sat_1.l15.c17.ctg.1	902	16.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	226	soxR	465	465	100.0	soxR.l15.c30.ctg.1	948	17.6	1	SNP	p	R20H	0	.	.	58	60	CGC	283	285	CGC	32;31;31	C;G;C	32;31;31	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	226	soxR	465	465	100.0	soxR.l15.c30.ctg.1	948	17.6	1	SNP	p	G121D	0	.	.	361	363	GGT	586	588	GGT	23;23;23	G;G;T	23;23;23	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	136	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	1125	9.2	1	SNP	p	A12S	0	.	.	34	36	GCA	510	512	GCA	26;26;25	G;C;A	26;26;25	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	48	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l6.c4.ctg.1	1004	3.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	1	46	APH_6__Id+	837	576	100.0	APH_6__Id+.l6.c4.ctg.1	719	3.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	1	46	APH_6__Id+	837	234	100.0	APH_6__Id+.l6.c4.ctg.2	263	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	16	40	sul2	816	282	100.0	sul2.l15.c30.ctg.1	336	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.;sul2
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	0	64	tetA	1200	286	100.0	tetA.l15.c30.ctg.1	365	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	0	64	tetA	1200	657	100.0	tetA.l15.c30.ctg.2	821	3.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	1	34	tetR	651	109	100.0	tetR.l15.c4.ctg.1	146	2.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	1	34	tetR	651	520	100.0	tetR.l15.c4.ctg.2	528	3.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	500	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2005	18.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
